Apnar Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.70 Cr
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.35 Cr
- Revenue Growth 67.61%
- Profit Growth 1156.71%
- Ebitda 28.54%
- Net Worth 15.13%
- Total Assets 14.06%
About Apnar Pharma
Apnar Pharma Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 December 2014 and has a history of Ten years and one month. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Apnar Research Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.70 Cr.
The company currently has active open charges totaling ₹50.35 Cr.
Swapnil Patel, Dharmesh Patel, and Umesh Patel serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73100GJ2014PTC081520
- Company No.
081520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Apnar Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapnil Patel  | Director | 12-Dec-2014 | Current |
Dharmesh Patel  | Director | 24-Jan-2015 | Current |
| Umesh Patel | Director | 25-Feb-2015 | Current |
Financial Performance of Apnar Pharma.
Apnar Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 67.61% increase. The company also saw a substantial improvement in profitability, with a 1156.71% increase in profit. The company's net worth Soared by an impressive increase of 15.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apnar Pharma?
In 2021, Apnar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apken Api Private LimitedSwapnil Patel, Dharmesh Patel and 1 more are mutual person
Charges (Loans)
₹50.35 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 30.49 Cr
- Hdfc Bank Limited : 19.87 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2022 | Others | ₹7.50 Cr | Open |
| 09 Dec 2021 | Others | ₹8.34 M | Open |
| 24 Aug 2020 | Others | ₹1.66 Cr | Open |
| 26 May 2020 | Hdfc Bank Limited | ₹19.87 Cr | Open |
| 16 Dec 2017 | Others | ₹11.49 Cr | Open |
How Many Employees Work at Apnar Pharma?
Apnar Pharma has a workforce of 95 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apnar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apnar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
